Robert B. Garland

Trifluoromethyl ketones as inhibitors of histone deacetylase

Robin R. Frey, Carol K. Wada, Robert B. Garland et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 147 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +13

Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC)

Michael L. Curtin, Robert B. Garland, H. Robin Heyman et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 113 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +13

Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa receptor

Jeffery A. Zablocki, Masateru Miyano, Robert B. Garland et al. · Journal of Medicinal Chemistry · 1993 · 107 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Asymmetric synthesis of quaternary carbon centers

A. I. MEYERS, Michael Harré, Robert B. Garland · Journal of the American Chemical Society · 1984 · 104 citations

Natural Sciences, Chemistry, Analytical Chemistry +7

Potent in Vitro and in Vivo Inhibitors of Platelet Aggregation Based Upon the Arg-Gly-Asp Sequence of Fibrinogen. (Aminobenzamidino)succinyl (ABAS) Series of Orally Active Fibrinogen Receptor Antagonists

Jeffery A. Zablocki, Joseph G. Rico, Robert B. Garland et al. · Journal of Medicinal Chemistry · 1995 · 104 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17